In a colon cancer study, CASP3 was found to play a role in tumour invasion and metastasis, and the deletion of CASP3 often indicates higher sensitivity to chemotherapy and radiation, suggesting that cleaved CASP3 may serve as a new therapeutic target in cancer (Zhou et al., 2018). The gene discussed is CASP3; the disease is colonic neoplasm.